- Latest Stories
- Commentary and Analysis
10:35AM ET 5/12/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
5:15AM ET 5/05/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
5:37PM ET 4/20/2022 MT NewswiresKeith Westby, Senior Vice President & COO, on April 18, 2022, sold 10,000 shares in Iveric Bio (ISEE) for $166,300. Following the Form 4 filing with the...
1:00PM ET 3/22/2022 MT NewswiresIVERIC bio (ISEE) shares were up more than 6.0% in Tuesday afternoon trading after Jefferies started coverage on the stock with a buy rating and a $27...
7:48AM ET 3/22/2022 MT NewswiresIVERIC bio (ISEE) has an average rating of buy and price targets ranging from $21 to $27, according to analysts polled by Capital IQ. (MT Newswires covers...
4:34PM ET 3/18/2022 MT NewswiresKeith Westby, Senior Vice President & COO, on March 16, 2022, sold 10,000 shares in Iveric Bio (ISEE) for $150,190. Following the Form 4 filing with the...
5:19AM ET 3/03/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
9:18AM ET 2/24/2022 MT NewswiresIVERIC Bio (ISEE) reported Thursday a Q4 diluted net loss of $0.29 per share, compared with a loss of $0.27 a year earlier. Analysts polled by Capital IQ...
5:23PM ET 2/17/2022 MT NewswiresKeith Westby, Senior Vice President & COO, on February 15, 2022, sold 10,000 shares in Iveric Bio (ISEE) for $151,634. Following the Form 4 filing with the...
8:27AM ET 2/07/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...